No Data
No Data
Trending Stocks Today | Cognition Therapeutics Shoots up 39.66% Post-Market
Express News | Cognition Therapeutics Shares Are Trading Higher After the Company Announced That It Will Host an Investor Presentation to Discuss Results From Its Phase 2 SHINE Study of CT1812 on Monday July 29, 2024
Cognition Therapeutics to Host Investor Webcast to Discuss Results From Proof-of-Concept Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer's Disease at 8:30am ET on Monday July 29, 2024
Express News | Rodman & Renshaw Reiterates Buy on Cognition Therapeutics, Maintains $14 Price Target
Express News | Cognition Therapeutics to Present Phase 2 SHINE Study of CT1812 In Mild-to-Moderate Alzheimer's Disease At Alzheimer's Association's International Conference
Results From Cognition Therapeutics' Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer's Disease Accepted for Presentation at AAIC
No Data
Salmon Klein : [Emoticon] are you already in? I missed the dip at 0.32
jimmy the trader OP Salmon Klein : I am
Andy-Lai Salmon Klein : Didn't you get it?
jimmy the trader OP Salmon Klein : All 4 of them
Salmon Klein jimmy the trader OP : you are the man!!! hehehe waiting for Momday premarket huh actually they all like wanting to run more isn't?
View more comments...